The COOPERATE trial

被引：9

作者：

Vogt, L ^{[1
]}

Laverman, GD ^{[1
]}

de Zeeuw, D ^{[1
]}

Navis, G ^{[1
]}

机构：

[1] Univ Groningen Hosp, Kidney Ctr, NL-9713 GZ Groningen, Netherlands

来源：

LANCET | 2003年 / 361卷 / 9362期

关键词：

D O I：

10.1016/S0140-6736(03)12803-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1055 / 1056

页数：2

共 5 条

[1]

APPERLOO AJ, 1994, KIDNEY INT, V45, P174

[2] Dual renin-angiotensin system blockade at optimal doses for proteinuria [J].

Laverman, GD ;

Navis, G ;

Henning, RH ;

de Jong, PE ;

dE Zeeuw, D .

KIDNEY INTERNATIONAL, 2002, 62 (03) :1020-1025

[3] RETRACTED: Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial (Retracted article. See vol. 374, pg. 1226, 2009) [J].

Nakao, N ;

Yoshimura, A ;

Morita, H ;

Takada, M ;

Kayano, T ;

Ideura, T .

LANCET, 2003, 361 (9352) :117-124

[4] Pathophysiology of progressive nephropathies [J].

Remuzzi, G ;

Bertani, T .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (20) :1448-1456

[5] Progression, remission, regression of chronic renal diseases [J].

Ruggenenti, P ;

Schieppati, A ;

Remuzzi, G .

LANCET, 2001, 357 (9268) :1601-1608

← 1 →